Rockefeller Capital Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $409K | Buy |
341,224
+16,544
| +5% | +$19.9K | ﹤0.01% | 1601 |
|
|
2025
Q1 | $351K | Buy |
324,680
+28,049
| +9% | +$30.3K | ﹤0.01% | 1568 |
|
|
2024
Q4 | $519K | Buy |
296,631
+135,075
| +84% | +$236K | ﹤0.01% | 1462 |
|
|
2024
Q3 | $312K | Buy |
161,556
+1,000
| +0.6% | +$1.93K | ﹤0.01% | 1536 |
|
|
2024
Q2 | $284K | Buy |
160,556
+890
| +0.6% | +$1.58K | ﹤0.01% | 1557 |
|
|
2024
Q1 | $433K | Buy |
159,666
+29,023
| +22% | +$78.7K | ﹤0.01% | 1514 |
|
|
2023
Q4 | $289K | Sell |
130,643
-1,125
| -0.9% | -$2.49K | ﹤0.01% | 1472 |
|
|
2023
Q3 | $382K | Buy |
131,768
+728
| +0.6% | +$2.11K | ﹤0.01% | 1365 |
|
|
2023
Q2 | $253K | Sell |
131,040
-3,000
| -2% | -$5.79K | ﹤0.01% | 1573 |
|
|
2023
Q1 | $261K | Hold |
134,040
| – | – | ﹤0.01% | 1667 |
|
|
2022
Q4 | $156K | Sell |
134,040
-17,000
| -11% | -$19.8K | ﹤0.01% | 1789 |
|
|
2022
Q3 | $166K | Buy |
151,040
+33,000
| +28% | +$36.3K | ﹤0.01% | 1729 |
|
|
2022
Q2 | $188K | Buy |
118,040
+5,000
| +4% | +$7.96K | ﹤0.01% | 1662 |
|
|
2022
Q1 | $405K | Buy |
113,040
+113,030
| +1,130,300% | +$405K | ﹤0.01% | 1399 |
|
|
2021
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 3887 |
|
|
2021
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 3774 |
|
|
2021
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 3529 |
|
|
2021
Q1 | – | Sell |
-5,715
| Closed | -$34K | – | 3329 |
|
|
2020
Q4 | $34K | Buy |
+5,715
| New | +$34K | ﹤0.01% | 1810 |
|